LKP Finance is a non-banking financial company primarily engaged in proprietary investment activities, including trading and holding equity shares, debt instruments, and mutual funds, while also providing corporate loans.
The company lacks a durable moat as evidenced by its volatile net margins and negative EPS growth despite high revenue CAGR. Its returns are entirely dependent on capital market fluctuations rather than unique intellectual property, cost advantages, or high switching costs, which is corroborated by the low average ROE of 8.1%.
Management has historically focused on proprietary trading and related-party lending. The recent total divestment of its subsidiary Bond Street Capital and the sale of immovable property to related parties suggest a liquidation or exit strategy rather than value-creating reinvestment.
The business collapsed as the disconnect between top-line growth and bottom-line erosion became permanent. The 2025 mass resignation of the board and management signaled a total breakdown in governance, leaving the company as a hollow shell for related-party transactions. Unresolved legal disputes and the lack of lender confirmations eventually led to a liquidity freeze, while the shift toward proprietary trading and asset liquidation destroyed any remaining operational value, proving that the high revenue growth was merely a vanity metric masking a decaying core.
RichFakir rates GYFTR Ltd's business quality as poor — 28/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as none.
On our model, GYFTR Ltd is trading far above our estimate of fair value (expensive on our lens); we rate its price expensive. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on GYFTR Ltd is: Avoid. We are steering clear of this one — the red flags below outweigh anything the price or numbers offer.
RichFakir's educational estimate of GYFTR Ltd's fair value is about ₹24 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →